2019

NEUROSCIENCE 2019

Axoltis Pharma announces to attend NEUROSCIENCE 2019, the 50th Annual Meeting of the Society for Neurosciences, on October 19-23th at Chicago, Il, USA. This is a great opportunity to meet with researchers from all over the world and arrange potential collaborative work. Dr Manuel Blanc, Chief Scientific Officer, will be delighted to meet you there.

 

PD Therapeutics Conference

Axoltis Pharma announces to attend The Parkinson’s Disease Therapeutics Conference on October 15th at New York City, NY, USA. This meeting is The Michael J. Fox Foundation’s annual scientific conference and the only one in the world focused exclusively on Parkinson’s disease drug development. Dr Manuel Blanc, Chief Scientific Officer, will be delighted to meet you there.

BioJapan 2019 & European Biotech Pharma Partnering Conference

Axoltis Pharma announces to attend BioJapan 2019. This Asia’s Premier Partnering Event for Biotechnology Industry will be held on October 9-11th at Pacifico Yokohama, Japan. On October 8th, Axoltis Pharma will also attend the European Biotech and Pharma Partnering Conference in Osaka, Japan. These are opportunities to meet us and discuss potential partnership for the development of our promising products. Dr Yann GODFRIN, Chief Executive Officer, will be delighted to meet you there.

BIO 2019

Axoltis Pharma announces to attend 2019 BIO International Convention on June 3-6 in Philadelphia, PA – USA, with participation to the Bio One-on-One Partnering event. Dr Manuel Blanc, Chief Scientific Officer, will be delighted to meet you there.

NeuroFrance 2019

Axoltis Pharma announces to attend NeuroFrance 2019 on May 22-24th in Marseille, France. This international colloque is organised by the French Society of Neuroscience. Dr Yann Godfrin, Chief Executive Officer, and Dr Manuel Blanc, Chief Scientific Officer, will be delighted to meet you there.